Approval · Notice of Compliance 8174 · 2006
CANTRACE: Notice of Compliance 8174
Issued July 27, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8174
- Date
- July 27, 2006
- Company
- Ipet Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Diagnostic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CANTRACE | Not yet assigned | — |
Medicinal ingredients
- FLUDEOXYGLUCOSE 18F 732 MBQ per ML